Navigation Links
FDA Approved Treatment for Painful Intercourse (Dyspareunia) Due to Menopause
Date:2/27/2013

ed, should be undertaken to rule out malignancy in postmenopausal women with undiagnosed persistent or recurring abnormal genital bleeding.

Breast Cancer: Osphena has not been adequately studied in women with breast cancer; therefore Osphena should not be used in women with known or suspected breast cancer or with a history of breast cancer.

Severe Hepatic Impairment: Do not use Osphena in women with severe hepatic impairment as it has not been studied.

Adverse Reactions: In clinical studies, the more commonly reported adverse reactions (greater than or equal to 1 percent) in patients treated with Osphena 60 mg compared to placebo were: hot flush (7.5 percent vs. 2.6 percent), vaginal discharge (3.8 percent vs. 0.3 percent), muscle spasms (3.2 percent vs. 0.9 percent), hyperhidrosis (1.6 percent vs. 0.6 percent), and genital discharge (1.3 percent vs. 0.1 percent).

Drug Interactions

  •     Do not use estrogens or estrogen agonists/antagonists or fluconazole concomitantly with Osphena.
  •     Moderate to Strong CYP3A4 inhibitors (e.g., ketoconazole, fluconazole) will increase Osphena (ospemifene) drug concentrations while moderate to strong CYP3A4, CYP2C9, or CYP2C19 inducers (e.g. rifampin) will decrease Osphena (ospemifene) drug concentrations.
  •     Coadministration of Osphena with drugs that inhibit CYP3A4 and CYP2C9 may increase the risk of Osphena related adverse reactions.
  •     Osphena had no effect on the pharmacokinetics of a single 10 mg dose of warfarin. The effect of Osphena on International Normalized Ration (INR) or prothrombin time (PT) was not studied.
  •     Osphena (ospemifene) is highly protein bound. Use cautiously with highly protein bound drugs as use with other highly protein-bound drugs may lead to increase exp
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. ASHA Approved Continuing Education Provider HomeCEUConnection.com Announces Two New Live, Interactive Webinars for California Speech-Language Pathologists.
2. EzW2Correction Software Was Approved By SSA To Print W-2C and W-3C On White Paper
3. Newly approved oral medication slows rheumatoid arthritis joint damage
4. Westbridge Agricultural Products Announces that Botector® has been EPA Approved as an Organic Biopesticide to Prevent Gray Mold in Grapes
5. First FDA approved subcutaneous implantable defibrillator available for patients
6. Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
7. Moffitt Cancer Center melanoma expert reviews unique adverse events with newly approved drug
8. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
9. Mayo Clinic offers newly approved treatment for acid reflux disease
10. Experimental Vitiligo Treatment Shows Promise in Mice
11. DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... for doctors. Could they work for patients, too? Could ... preventive health services more? In some cases, yes, according ... in Australia, and colleagues. Their work, looking at why ... to change risky health behaviors, indicates that incentives are ...
... Can dementias and mild cognitive impairment be influenced in ... the subject of a study reported by Thorleif Etgen ... rzteblatt International (Dtsch Arztebl Int 2011; 108[44]: 743-50). ... mild cognitive impairments and even dementia, which means that ...
... a woman or a parent and a baby, we can still ... related. How do we know that people are part of a ... of Vision increases our understanding of the brain,s ability to ... to see the family resemblance between faces that have some underlying ...
... with coronary artery disease were almost three times as ... treatment to arterial plaque than their White European counterparts, ... the International Journal of Clinical Practice . They ... and require urgent treatment. Researchers carried out a ...
... with dexpramipexole a novel drug believed to prevent ... most of a cell,s energy appears to slow ... (ALS). Promising results of a phase 2 trial ... Medicine. Some preliminary results of the study were ...
... , SUNDAY, Nov. 20 (HealthDay News) -- A good night,s ... a new study. The findings suggest that age-related brain ... the memory problems that can occur in older adults, the ... older adults who learned how to navigate through a series ...
Cached Medicine News:Health News:It pays to be healthier 2Health News:New research sheds light on how we see family resemblance in faces 2Health News:South Asian patients require 3 times as much repeat angioplasty as white Europeans 2Health News:South Asian patients require 3 times as much repeat angioplasty as white Europeans 3Health News:Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial 2Health News:Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial 3
(Date:1/15/2014)... NEW YORK , Jan. 15, ... a new market research report is ... Global Markets and Technologies ... Focus on Routes of Administration ... STUDY OBJECTIVES A ...
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than ... painless for patients to self-inject prescription drugs in the ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... is expected to grow to $220B by 2018, according ... new type of injector that does not exist today ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) ... the fourth quarter of 2013 on Monday, February 3, ... for release after the close of trading. ... hold a conference call to discuss the operating highlights ... months ended December 31, 2013 on February 3, 2014, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... PRXL ), a leading global biopharmaceutical services ... one of two strategic partners by UCB, a global ... PAREXEL will work with UCB to drive innovation ... and cost effectiveness. The agreement is effective ...
... Reportlinker.com announces that a new market research ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203103/The-Outlook-for-Pharmaceuticals-in-Central--Eastern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... Europe is estimated at US$63.6 billion at ...
Cached Medicine Technology:UCB and PAREXEL Sign Strategic Partnership Agreement 2UCB and PAREXEL Sign Strategic Partnership Agreement 3UCB and PAREXEL Sign Strategic Partnership Agreement 4The Outlook for Pharmaceuticals in Central & Eastern Europe 2The Outlook for Pharmaceuticals in Central & Eastern Europe 3The Outlook for Pharmaceuticals in Central & Eastern Europe 4
... System supports approaches to Admitting/Discharge/Transfer ... record keeping functions using a ... facilities and cut across institutional ... community clinics, physician, agency, nursing ...
... Dairylands Clinical Information Management ... suite of integrated applications ... departments and automate administrative ... The applications allow organizations ...
... include a Patient Face Sheet, ... many as six custom tabs, ... information is important for you ... Import Manager utility lets you ...
... WEBeDoctor® Physician-office® is an ... physicians, (Solo practice, group ... to complete their normal ... It is a front ...
Medicine Products: